Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Orient Europharma Co., Ltd. (4120) Income Statement

Orient Europharma Co., Ltd. Income Statement

Last quarter (Q2 2026), Orient Europharma Co., Ltd.'s total revenue was NT$1.19B, an increase of 5.57% from the same quarter last year. In Q2, Orient Europharma Co., Ltd.'s net income was NT$-183.01M. See Orient Europharma Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
NT$ 4.60BNT$ 4.39BNT$ 4.59BNT$ 4.73BNT$ 4.77B
NT$ 2.10BNT$ 2.07BNT$ 2.15BNT$ 2.03BNT$ 2.15B
NT$ 2.41BNT$ 2.05BNT$ 2.08BNT$ 2.18BNT$ 2.25B
Depreciation and AmortizationNT$ 188.78MNT$ 206.66MNT$ 216.26MNT$ 194.31MNT$ 191.09M
NT$ -121.76MNT$ 183.90MNT$ 596.88MNT$ -34.15MNT$ 133.32M
NT$ -310.54MNT$ 13.32MNT$ 84.55MNT$ -259.00MNT$ -57.77M
NT$ 37.51MNT$ -143.31MNT$ 171.70MNT$ -178.20MNT$ 180.45M
NT$ -273.03MNT$ -129.99MNT$ 256.25MNT$ -328.13MNT$ 84.77M
NT$ -567.39MNT$ -283.93MNT$ 143.94MNT$ -310.80MNT$ 120.17M
Per Share Metrics
Basic EPSNT$ -6.54NT$ -3.27NT$ 1.66NT$ -3.58NT$ 1.39
Diluted EPSNT$ -6.54NT$ -3.27NT$ 1.66NT$ -3.58NT$ 1.38
Weighted Average Shares Outstanding86.76M86.75M86.71M86.75M86.75M
Weighted Average Shares Outstanding (Diluted)86.76M86.75M86.95M86.75M86.96M

Currency in TWD

Orient Europharma Co., Ltd. Earnings and Revenue History

-4B04B8B-16 %-8 %0 %8 %EarningsProfit Margin2019202020212022202320242025RevenueEarningsProfit Margin